Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHSE:688336) shares have continued their recent momentum with a 28% gain in the last month alone. Looking further back, the 11% rise over the last twelve months isn’t too bad notwithstanding the strength over the last 30 days.
In spite of the firm bounce in price, given about half the companies in China have price-to-earnings ratios (or “P/E’s”) above 40x, you may still consider Sunshine Guojian Pharmaceutical (Shanghai) as an attractive investment with its 24.4x P/E ratio. However, the P/E might be low for a reason and it requires further investigation to determine if it’s justified.
Sunshine Guojian Pharmaceutical (Shanghai) certainly has been doing a good job lately as its earnings growth has been positive while most other companies have been seeing their earnings go backwards. One possibility is that the P/E is low because investors think the company’s earnings…
